NCT02749513View on ClinicalTrials.gov

Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

October 31, 2022

Conditions
Esophageal Cancer
Interventions
DRUG

Itraconazole

Trial Locations (1)

75216

Dallas VA Medical Center, Dallas

Sponsors
All Listed Sponsors
lead

Dallas VA Medical Center

FED

NCT02749513 - Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients | Biotech Hunter | Biotech Hunter